Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Xenova updates R&D reorganization status

July 25, 2003

Orphan drug status awarded to Transgene's Ad-IFNgamma

July 25, 2003

Cell Genesys and Novartis enter oncolytic virus therapy alliance

July 25, 2003

Pfizer patent covers new bicyclic FTase inhibitors

July 25, 2003

Pemetrexed in combination with cisplatin significantly extends survival in mesothelioma patients

July 25, 2003

Discodermolide analogue NC2-86 has promising biological profile

July 24, 2003

G-quartet oligodeoxynucleotide targeting Stat3 demonstrates antitumor activity

July 24, 2003

WX-508, an orally available uPA inhibitor as a promising new cancer therapeutic

July 24, 2003

Selective MRP1-mediated multidrug resistant modulator characterized by Vertex

July 24, 2003

Austrianova's cell therapy receives European orphan drug status

July 23, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 7, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Regulatory actions for May 5, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Adma, Applied...